FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition <i>via</i> the Wnt/β-catenin signaling pathway

  • Yang Zhihong
    Department of Pharmacology, School of Pharmacy, Qingdao University
  • Ji Lixia
    Department of Pharmacology, School of Pharmacy, Qingdao University
  • Jiang Guohui
    Department of Pharmacology, School of Pharmacy, Qingdao University
  • Liu Ranran
    Department of Pharmacology, School of Pharmacy, Qingdao University
  • Liu Zhantao
    Department of Pharmacology, School of Pharmacy, Qingdao University
  • Yang Yuecheng
    Department of Pharmacology, School of Pharmacy, Qingdao University
  • Ma Qingxia
    Department of Pharmacology, School of Pharmacy, Qingdao University
  • Zhao Hongqin
    Department of Pharmacology, School of Pharmacy, Qingdao University

Search this article

Description

<p>The aim of the current study was to investigate the effects of FL118, a novel camptothecin analogue, on migration and invasion of human breast cancer cells and the underlying mechanisms of those effects. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and a plate clone formation assay were used to examine inhibition of the proliferation of MDA-MB-231 cells by FL118. Cell cycle distribution was detected using flow cytometry. A wound healing assay and a transwell assay were performed to detect the effects of FL118 on migration and invasion of MDA-MB-231 cells, respectively. qRT-PCR, Western blotting, and immunocytochemistry were used to study the effects of FL118 on expression of epithelial-mesenchymal transition (EMT)-related molecules and Wnt/ β-catenin signaling components in MDA-MB-231 cells. The current results indicated that FL118 inhibited the proliferation, migration and invasion of MDA-MB-231 cells in a dose- and time-dependent manner. FL118 caused MDA-MB-231 cells to accumulate in the S phase. FL118 significantly suppressed the expression of vimentin while enhancing the expression of E-cadherin. Moreover, decreased expression of β-catenin and its targets survivin and cyclin Dl was detected in the nucleus of MDA-MB-231 cells. Taken together, the current results suggest that FL118 inhibited Wnt/β-catenin signaling, leading to suppressed EMT and decreased migration and invasion of breast cancer cells.</p>

Journal

  • BioScience Trends

    BioScience Trends 12 (1), 40-46, 2018

    International Research and Cooperation Association for Bio & Socio-Sciences Advancement

Citations (2)*help

See more

References(28)*help

See more

Details 詳細情報について

Report a problem

Back to top